Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes

Journal of Investigative Dermatology Symposium Proceedings

Volumn 4, Issue 2, 1999, Pages 105-109

  Funasaka, Yoko ^a   Sato, Hirofumi ^a   Chakraborty, Ashok K ^a,b   Ohashi, Akiko ^a   Chrousos, George P ^c   Ichihashi, Masamitsu ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Immunohistochemistry; RT PCR

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PROOPIOMELANOCORTIN;

ADVANCED CANCER; CELL CULTURE; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA CELL; NEVUS CELL; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0032878889     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jidsp.5640192     Document Type: Conference Paper

References (48)

1. Antoni FA: Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351-362, 1986
2. Auchus RJ, Mastorakos G, Friedman TC, Chrousos GP: Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome. J Endocrinol Invest 17:447-452, 1994
3. Bennett DC, Dexter TJ, Ormerod EJ, Hart IR: Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. Cancer Res 46:3239-3244, 1986
4. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T. Scholzen T, Luger TA: Evidence for the differential expression of the functional α- melanocyte stimulating hormone receptor MC-1 on human monocytes. J Immunol 158:3378-3384, 1997
5. Blalock JE: A molecular basis for bidirectional communication between the immune and neuroendocrine systems (Reveiw). Physiol Rev 69:1-32, 1989
6. Bregman MD, Abdel-Malek ZA, Meyskens FL Jr: Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone. Exp Cell Res 157:419-428, 1985
7. Chakraborty AK, Funasaka Y, Slominski A, Ennak G, Hwang J, Pawelek JM, Ichihashi M: Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by UVB. Biochim Biophys Acta 1313:130-138, 1996
8. Ciocca DR, Puy LA, Fasoli LC, et al: Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivties in biopsies from breast cancer patients. Breast Cancer Res Treat 15:175-184, 1990
9. Fabbri A, Tinajero JC, Dufau ML: Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis. Endocrinology 127:1541-1543, 1990
10. Funasaka Y, Boulton T, Cobb M, et al: c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activatcd protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197-209, 1992
11. Funasaka Y, Chakraborty AK, Hayashi Y, et al: Modulation of melanocyte stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of UVβ, IL-1α, L-1β, ET-1, and TNF-α. Br J Dermatol 139:216-224, 1998
12. Ghanem G, Verstegen J, Libert A, Amould R, Lejeune F: Alpha-melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. Pig Cell Res 2:519-523, 1989
13. Ghanem G, Loir B, Hadley M. et al: Partial characterization of IR- α -MSH peptides found in melanoma tumors. Peptides 13:989-994, 1992
14. Hahne M, Rimoldi D, Schröter M, et al: Melanoma cell expression of Fas (Apo-1/C-D95) ligand: implications for tumor immune escape. Science 274:1363-1366, 1996
15. Halaban R, Gosh S, Duray P, Kirkwood JM, Lemer AB: Human melanocytes cultured from nevi and melanomas. J Invest Deramtol 87:95-101, 1986
16. Kameyama K, Takezaki S, Kanzaki T, Nishiyama S: HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis. J Invest Dermatol 87:313-318, 1986
17. Lahm H, Amstad P, Yilmaz A, et al: Interleukin 4 down-regulates expression c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 6:1111-1118, 1995
18. Lunec J, Pieron C, Sherbet GV, Thody AJ: Alpha-melanocyte stimulating hormone immunoreactivity in melanoma cells. Pathobiol 58:193-197, 1990
19. Lunec J, Pieron C, Thody AJ: MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 2:5-12, 1992
20. Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C, Gravams A: The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 79:185-189, 1995
21. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A: Regulation of the promoter of the human cortocotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinolgy 64:85-92, 1996
22. Mastorakos G, Webster EL, Friedman TC, Chrousos GP: Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J Clin Invest 92:961-968, 1993
23. Mastorakos G, Scopa CD, Vryonidou A, et al: Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J Clin Endocrinol Metab 79:1191-1197, 1994
24. Nagahama M, Funasaka Y, Fernandez-Frez L, Ohashi A, Chakraborty AK, Ueda M, Ichihashi M: Immunoreactivity of α-melanocyte stimulating hormone, adrenocorticotropic hormone, and β-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Br J Dermatol 138:981-985, 1998
25. Nagashima Y, Miyagi Y, Aoki I, et al: Establishment and characterizaton of a malignant melanoma cell line (YP-MEL) derived from a patient with neurocutaneous melanosis. Path Res Pract 190:178-185, 1994
26. Ohashi A, Funasaka Y, Ueda M, Ichihashi M: c-Kit receptor expression in cutaneous melanoma and benign melanocytic nevi. Melanoma Res 6:25-30, 1996
27. Orth D: Corticotropin-releasing hormone in humans. Endocr Rev 13:164-191, 1992
28. Owens MJ, Nemeroff CB: Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473, 1991
29. Petraglia F, Sutton S, Vale W, Plotsky P: Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 120:1083-1088, 1987
30. Petrusz P, Merchenthaler I, Maderdrut JL, Vigh S, Schally A: Corticotropin-releasing factor (CRF) -like immunoreactivity in the vertebrate endocrine pancreas. Proc Natl Acad Sci USA 80:1721-1725, 1983
31. Petrusz P, Merchenthaler I, Ordronneau P, Maderdrut JL, Vigh S, Schally AV: Corticotropinreleasing factor-like immunoreactivity in the gastro-entero-pancreatic endocrine system. Peptides 5:71-72, 1984
32. Rivier C, Rivier J, Vale W: Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. Science 234:205-208, 1986
33. Ruzicka BB, Akil H. Differential cellular regulation of pro-opiomelanocortin by interleukin-l-beta and corticotropin-releasing hormone. Neuroendocrinology 61:136-151:, 1995
34. Schauer E, Trautinger F, Köck A, et al: Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 93:2258-2262, 1994
35. Scopa CD, Mastorakos G, Friedman TC, Melachrinou M, Merino MJ, Chrousos GP: Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol 145:1159-1167, 1994
36. Sheppard JR, Koestler TP, Corwin SP, et al: Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature 308:544-547, 1984
37. Slominski A, Mihm MC: Potential mechanism of skin response to stress. Int J Dermatol 35:849-851, 1996
38. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz JE, Mihm M: Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374:113-116, 1995
39. Slominski A, Baker J, Ermak G, Chakraborty A, Pawelek J: Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 399:175-176, 1996
40. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J: Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 83:1020-1024, 1998
41. Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K: Distribution and characterization of immunoreactive cortiocotropin-releasing factor in human tissues. J Clin Endocrinol Metab 55:861-866, 1984
42. Tatro JB, Atkins M, Mier JW, et al: Melanotropin receptors demonstrated in situ in human melanoma. J Clin Invest 85:1825-1832, 1990
43. Thompson RC, Seasholtz AF, Herbert E: Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol Endocrinol 1:363-370, 1987
44. Usui T, Nakai Y, Tsukada T, Jingami H, Takahashi H, Fukata J, Imura H: Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol Endocrinol 2:871-875, 1988
45. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson A: Chemical and biological characterization of corticotropin-releasing factor. Recent Prog Horn Res 39:245-267, 1983
46. Vamvakopoulos NC, Chrousos GP: Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflamatory reaction. Endocr Rev 15:409-420, 1994
47. Zoumakis E, Margioris AN, Makrigiannakis A, Stournaras C, Gravanis A: Human endometrium as a neuroendocrine tissue: expression, regulation and bilogical roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides. J Endocrinol Invest 20:159-167, 1997
48. Zubair A, Lakshmi MS, Sherbet GV: Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma. Anticancer Res 12:399-402, 1992